Frances O’Brien
Impact in
- Clinical Biochemistry top 0.1%
- Bacterial Identification and Susceptibility Testing
- Infectious Diseases top 0.5%
- Antimicrobial Resistance in Staphylococcus
Papers in
-
- Bacterial Identification and Susceptibility Testing 22
-
- Antimicrobial Resistance in Staphylococcus 43
- Co-authors
- Geoffrey W. CoombsWarren B. GrubbJohn W. PearmanJan BellFred C. TenoverW.B. GrubbJohn TurnidgeJulie Pearson
- Journals
- Journal of Clinical Microbiology (8 papers)Journal of Antimicrobial Chemotherapy (6 papers)Pathology (4 papers)Antimicrobial Agents and Chemotherapy (4 papers)Gastroenterology (3 papers)
- Partner nations
- AustraliaUnited StatesUnited Kingdom
In The Last Decade
Frances O’Brien
59 papers receiving 3.5k citations
Hit Papers
Peers
Comparison fields: 5 of 136
- Clinical Biochemistry 1.4k
- Infectious Diseases 2.6k
- Molecular Medicine 243
- Applied Microbiology and Biotechnology 65
- Molecular Biology 2.0k
Countries citing papers authored by Frances O’Brien
This map shows the geographic impact of Frances O’Brien's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frances O’Brien with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frances O’Brien more than expected).
Fields of papers citing papers by Frances O’Brien
This network shows the impact of papers produced by Frances O’Brien. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frances O’Brien. The network helps show where Frances O’Brien may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Frances O’Brien, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 28 | |
| 2 | 2023 | 40 | |
| 3 | 2020 | 18 | |
| 4 | 2016 | 82 | |
| 5 | 2016 | 12 | |
| 6 | 2016 | 35 | |
| 7 | 2015 | 72 | |
| 8 | 2014 | 24 | |
| 9 | 2012 | 44 | |
| 10 | 2010 | 182 | |
| 11 | 2010 | 34 | |
| 12 | 2008 | 303 | |
| 13 | 2006 | 91 | |
| 14 | 2005 | 197 | |
| 15 | 2004 | 129 | |
| 16 | 2003 | 15 | |
| 17 | 2002 | 67 | |
| 18 | 2002 | 12 | |
| 19 | 2001 | 48 | |
| 20 | 1997 | 43 |
About Frances O’Brien
Frances O’Brien is a scholar working on Clinical Biochemistry, Infectious Diseases, Biotechnology, Molecular Biology and Immunology and Allergy, having authored 59 papers that have together received 3.6k indexed citations. Recurring topics across this work include Antimicrobial Resistance in Staphylococcus (43 papers), Bacterial biofilms and quorum sensing (25 papers), Bacterial Identification and Susceptibility Testing (22 papers), Streptococcal Infections and Treatments (8 papers), Bacterial Genetics and Biotechnology (5 papers), Probiotics and Fermented Foods (4 papers), Infective Endocarditis Diagnosis and Management (4 papers) and Gut microbiota and health (4 papers). The work is most often cited by research in Clinical Biochemistry (1.4k citations), Infectious Diseases (2.6k citations), Molecular Medicine (243 citations), Applied Microbiology and Biotechnology (65 citations) and Molecular Biology (2.0k citations). Frances O’Brien has collaborated with scholars based in Australia, United States and United Kingdom. Frequent co-authors include Geoffrey W. Coombs, Warren B. Grubb, John W. Pearman, Jan Bell, Fred C. Tenover, W.B. Grubb, John Turnidge, Julie Pearson, Teruyo Ito and Keiichi Hiramatsu. Their work appears in journals such as Journal of Clinical Microbiology, Journal of Antimicrobial Chemotherapy, Pathology, Antimicrobial Agents and Chemotherapy and Gastroenterology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.